Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-27T19:39:05.981Z Has data issue: false hasContentIssue false
  • English
  • Français

Opioids May be Appropriate for Chronic Pain

Published online by Cambridge University Press:  01 January 2021

Paul J. Christo
Get access Rights & Permissions [Opens in a new window]

Abstract

Patients living with chronic pain require appropriate access to opioid therapy along with improved access to pain care and additional therapeutic options. It's both medically reasonable and ethical to consider opioid therapy as a treatment option in the management of chronic, non-cancer pain for a subset of patients with severe pain that is unresponsive to other therapies (e.g., injections, other medications, integrative strategies), negatively impacts function or quality of life, and will likely outweigh the potential harms. This paper will examine opioid therapy in the setting of the opioid epidemic, why critics feel that the CDC guideline has resulted in harsh consequences for patients and their physicians, and the rationale for opioid therapy as a means of providing ethical and compassionate pain care.

Type
Symposium Articles
Information
Journal of Law, Medicine & Ethics , Volume 48 , Issue 2: Opioid Controversies: The Crisis — Causes and Solutions , Summer 2020 , pp. 241 - 248
Copyright
Copyright © American Society of Law, Medicine & Ethics 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Institute of Medicine (US) Committee on Advancing Pain Research, Care, and Education, Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research (Washington, DC: National Academies Press (US), 2011).Google Scholar
Lohman, D., Schleifer, R., and Amon, J. J., “Access to Pain Treatment as a Human Right,” BMC Medicine 8, no. 8 (2010): 1–9Google Scholar
Stewart, W.F., Ricci, J.A., Chee, E., et al., “Lost Productive Time and Cost Due to Common Pain Conditions in the U.S. Work-force,” JAMA 290 (2003): 2443-2454.CrossRefGoogle Scholar
Helme, R. and Gibson, S., “Pain in Older People,” in Epidemiology of Pain, ed. Crombie, I.K. (Seattle, WA: IASP Press, 1999): 103-112; Farrell, M.J., “Pain and Aging,” American Pain Society Bulletin 10 (2000): 8-12.Google Scholar
Van Zee, A., “The Promotion and Marketing of Oxycontin: Commercial Triumph, Public Health Tragedy,” American Journal of Public Health 99 (2009): 221-227.CrossRefGoogle Scholar
National Academies of Sciences, Engineering, and Medicine Committee on Pain Management and Regulatory Strategies to Address Prescription Opioid Abuse, Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use (Washington, DC: National Academies Press; 2017).Google Scholar
Frieden, T.R. and Houry, D., “Reducing the Risks of Relief-The CDC Opioid-Prescribing Guideline,” New England Journal of Medicine 65, no. RR-1 (2016); Dowell, D., Haegerich, T.M., and Chou, R., “CDC Guideline for Prescribing Opioids for Chronic Pain — United States, 2016,” JAMA 315, no. 15 (2016): 1624-1645.Google Scholar
Tang, N. and Crane, C., “Suicidality in Chronic Pain: Review of the Prevalence, Risk Factors and Psychological Links,” Psychological Medicine 36, no. 5 (2006): 575-586.CrossRefGoogle Scholar
Lynch, M.E., “The Need for a Canadian Pain Strategy,” Pain Research and Management 16, no. 2 (2011): 77-80.CrossRefGoogle Scholar
Jay, G.W. and Barkin, R.L., “Perspectives on the Opioid Crisis from Pain Medicine Clinicians,” Disease-a-Month 64, no. 10 (2018): 451–466CrossRefGoogle Scholar
U.S. Department of Health and Human Services (HHS), “What is the U.S. Opioid Epidemic?” available at <https://www.hhs.gov/opioids/about-the-epidemic/index.html> (last visited April 2, 2020).+(last+visited+April+2,+2020).>Google Scholar
Id.Google Scholar
Seth, P., Rudd, R.A., Noonan, R.K., et al., “Quantifying the Epidemic of Prescription Opioid Overdose Deaths,” AJPH Surveillance 108, no. 4 (2018): 500-502; Rudd, R.A., Zibbell, N. Aleshire, , , J.E., et al., “Increases in Drug and Opioid Overdose Deaths — U.S., 2000-2014,” The Morbidity and Mortality Weekly Report 64 (2016): 1378-1382CrossRefGoogle Scholar
Wide-ranging online data for epidemiologic research (WONDER) (Atlanta, GA: CDC, National Center for Health Statistics; 2017), available at <http://wonder.cdc.gov> (last visited April 2, 2020).+(last+visited+April+2,+2020).>Google Scholar
Hannah, H.A., Arambula, K., and Ereman, R., et al., “Using Local Toxicology Data for Drug Overdose Mortality Surveil-lance,” Journal of Public Health Informatics 9, no. 1 (2017): e143.Google Scholar
Shatman, M.E. and Ziegler, S.J., “Pain Management, Prescription Opioid Mortality, and the CDC: Is the Devil in the Data?” Journal of Pain Research 10 (2017): 2489-2495.CrossRefGoogle Scholar
Warner, M., Trinidad, J.P., Bastian, B.A., et al., “Drugs Most Frequently Involved in Drug Overdose Deaths: United States, 2010-2014,” National Vital Statistics Report 65, no. 10 (2016): 1-15.Google Scholar
Guy, G.P. Jr., Zhang, K., Bohm, M.K., et al., “Vital Signs: Changes in Opioid Prescribing in the United States. 2006-2015,” MMWR Morbidity and Mortality Weekly Report 66 (2017): 697-704.CrossRefGoogle Scholar
Seth, P., Rudd, R.A., Noonan, R.K., et al., “Quantifying the Epidemic of Prescription Opioid Overdose Deaths,” American Journal of Public Heath Surveillance 108, no. 4 (2018): 500-502.CrossRefGoogle Scholar
O'Donnell, J.K., Halpin, J., Mattson, C., et al., “Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700 — 10 States, July-Dec. 2016,” MMWR Morbidity and Mortality Weekly Report 66, no. 43 (2017).Google Scholar
Rudd, supra note 13.Google Scholar
O'Donnell, supra note 20.Google Scholar
Seth, supra note 19.Google Scholar
Seth, supra note 19.Google Scholar
Automation of Reports and Consolidated Orders System (ARCOS) of the Drug Enforcement Agency: 1999. Transactional Data Warehouse: 2015.Google Scholar
Meghani, S.H. and Vapiwala, N., “Bridging the Critical Divide in Pain Management Guidelines from the CDC, NCCN, and ASCO for Cancer Survivors,” JAMA Oncology 4, no. 10 (2018): 1323-1324.CrossRefGoogle Scholar
“Addiction Psychiatrist Questions Involuntary Tapering of Opioid,” available at <https://youtube/pRmPizyuZFM> (last accessed Feb. 2019); Ziegler, S.J., “Patient Abandonment in Name of Opioid Safety,” Pain Medicine 14, no. 3 (2013): 323-324; “Why I am Closing My Pain Practice?” available at <https://www.painnewsnetwork.org/stories/2018/1/17/why-iam-closing-my-pain-practice> (last visited April 2, 2020).CrossRefGoogle Scholar
Bonnie, R.J., Schumacher, M.A., Clark, J.D., et al., “Pain Management and Opioid Regulation: Continuing Public Health Challenges,” American Journal of Public Health 109, no. 1 (2019): 31-34; Hoppe, J.A., McStay, C., Sun, B.C., Capp, R., “Emergency Department Attending Physician Variation in Opioid Prescribing in Low Acuity Back Pain,” Western Journal of Emergency Medicine 18, no. 6 (2017): 1135-1142.CrossRefGoogle Scholar
Dowell, D., Haegerich, T., and Chou, R., “No Shortcuts to Safer Opioid Prescribing,” New England Journal of Medicine 380 (2019): 2285-2287.CrossRefGoogle Scholar
Brennan, F., Obs, D., Lohman, D., et al., “Access to Pain Management as a Human Right,” American Journal of Public Health 109, no. 1 (2019): 61-65.Google Scholar
Nowak, M. and Hunt, P., special rapporteurs on the question of torture and the right of everyone to the highest attainable standard of physical and mental health. Letter to the vice-chairperson of the Commission on Narcotic Drugs, December 10, 2008, available at <http://www.ohchr.org/documents/issues/women/WRGS/health/GC14.pdf> (last visited April 2, 2020).+(last+visited+April+2,+2020).>Google Scholar
Brennan, supra note 30.Google Scholar
Meghani, supra note 26; Ruta, N.S. and Ballas, S.K., “The Opioid Drug Epidemic and Sickle Cell Disease: Guilt by Association,” Pain Medicine 17, no. 10 (2016): 1793-1798.CrossRefGoogle Scholar
Ruta, id.Google Scholar
“Las Vegas hospital ordered to pay nearly $43M to family of dead woman,” Las Vegas Review Journal, January 25, 2019, available at <https://www.reviewjournal.com/local/local-las-vegas/las-vegas-hospital-ordered-to-pay-nearly-43m-to-family-of-dead-woman-1582367/> (last visited April 2, 2020).+(last+visited+April+2,+2020).>Google Scholar
McGillion, M., L'Allier, P. L., Arthur, H., Watt-Watson, J., Svorkdal, N., Cosman, T., Taenzer, P., Nigam, A., Malysh, L., and S. Canadian Cardiovascular, “Recommendations for Advancing the Care of Canadians Living with Refractory Angina Pectoris: A Canadian Cardiovascular Society Position Statement,” Canadian Journal of Cardiology 25, no. 7 (2009): 399-401; Phillips, T.C. et al., “Painful HIV-Associated Sensory Neuropathy,” Pain Clinical Updates 18, no. 3 (2010): 1-8; Deandrea, S., Montanari, M., Moja, L., and Apolone, G., “Prevalence of Under-treatment in Cancer Pain. A Review of Published Literature,” Annals of Oncology 19 (2008): 1985-1991.CrossRefGoogle Scholar
Dowell, supra note 7.Google Scholar
Carinci, A.J., Pritzlaff, S., and Moore, A., “Recommendations for Classes of Medications in Older Adults,” in Effective Treatments for Pain in the Older Patient, Cordts, G.A. and Christo, P.J., ed. (New York, NY: Springer, 2019).Google Scholar
“Pharmacological Management of Persistent Pain in Older Persons,” American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons, Journal of American Geriatrics Society 57, no. 8 (2009): 1331–1346.CrossRefGoogle Scholar
“American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults,” American Geriatrics Society 2015 Beers Criteria Update Expert Panel, Journal of American Geriatrics Society 63, no. 11 (2015): 1-20.Google Scholar
Id.Google Scholar
Supra note 39.Google Scholar
Abdulla, A., Adams, N., Bone, M., et al., British Geriatric Society, Age and Ageing 42, Suppl. 1 (2013): i1-57.Google Scholar
Gibson, S.J. and Lussier, D., “Prevalence and Relevance of Pain in Older Persons,” Pain Medicine 13, Suppl. 2 (2012): S23-6.CrossRefGoogle Scholar
Federal Interagency Forum on Aging-Related Statistics, “Older Americans 2012: Key Indicators of Well-Being,” Federal Inter-agency Forum on Aging-Related Statistics (Washington, DC: U.S. Government Printing Office; 2012).Google Scholar
Christo, P.J., Aches and Gains. A Comprehensive Guide to Overcoming Your Pain (Boulder, CO: Bull Publishing, 2017).Google Scholar
Wegrzyn, E.L., Chaghtai, A.M., Argoff, C.E., et al., “The CDC Opioid Guideline: Proponent Interpretation Has Led to Misinformation,” Clinical Pharmacology & Therapeutics 103, no. 6 (2018): 950-953; Schnoll, S.H., “Misconceptions and Realities of the Prescription Opioid Epidemic,” Clinical Pharmacology & Therapeutics (2018): 963-965.CrossRefGoogle Scholar
Dasgupta, N. et al., “Cohort Study of the Impact of High-Dose Opioid Analgesics on Overdose Mortality,” Pain Medicine 17 (2016): 85-98.Google Scholar
Adams, E.H. et al., “A Comparison of the Abuse Liability of Tramadol, NSAIDS, and Hydrocodone in Patients with Chronic Pain,” Journal of Pain Symptom Managment 31 (2006): 465-476.CrossRefGoogle Scholar
Dasgupta, supra note 48; Powell, supra note 7.Google Scholar
Fishbain, D.A., Cole, B., Lewis, J., et al., “What Percentage of Chronic Nonmalignant Pain Patients Exposed to Chronic Opioid Analgesic Opioid Therapy Develop Abuse/Addiction and/or Aberrant Drug-Related Behaviors? A Structured Evidence-Based Review,” Pain Medicine 9, no. 4 (2008): 444-459; Minozzi, S., Amato, L., and Davoli, M., “Development of Dependence Following Treatment with Opioid Analgesics for Pain Relief: A Systematic Review,” Addiction 108, no. 4 (2013): 688-698.CrossRefGoogle Scholar
Volkow, N.D. and McLelllan, T.M., “Opioid Abuse in Chronic Pain — Misconceptions and Mitigation Strategies,” New England Journal of Medicine 374, no. 13 (2016): 253-1263.CrossRefGoogle Scholar
Cheatle, M.D., Gallagher, R.M., and O'Brien, C.P., “Low Risk of Producing an Opioid Use Disorder in Primary Care by Prescribing Opioids to Prescreened Patients with Chronic Non-cancer Pain,” Pain Medicine 19, no. 4 (2017): 764–773.CrossRefGoogle Scholar
Boscarino, J.A., Hoffman, S.N., and Han, J.J., “Opioid Use Disorder Among Patients on Long-Term Opioid Therapy: Impact of Final DSM-5 Diagnostic Criteria on Prevalence and Correlates,” Substance Abuse Rehabilitation 6 (2015): 83-91.CrossRefGoogle Scholar
Furlan, A.D., Sandoval, J.A., Mailis-Gagnon, A., and Tunks, E., “Opioids for CNCP: A Meta-Analysis of Effectiveness and Side Effects,” CMAJ 174, no. 11 (2006): 1589-1594.CrossRefGoogle Scholar
Schnoll, supra note 47; Wegrzyn, E.L., Chaghtai, A.M., Argoff, C.E., et al., “The CDC Opioid Guideline: Proponent Interpretation Has Led to Misinformation,” Clinical Pharmacology & Therapeutic 103, no. 6 (2018): 950-953.CrossRefGoogle Scholar
Finnerup, N.B., Attal, N., and Haroutounian, S. et al., “Pharmacotherapy for Neuropathic Pain in Adults: A Systematic Review and Meta-Analysis,” Lancet Neurology 14, no. 2 (2015): 162-173.CrossRefGoogle Scholar
Raja, S.N. Haythornthwaite, J.A., Pappagallo, M. et al., “Opioids Versus Antidepressants in Postherpetic Neuralgia: A Randomized, Placebo-Controlled Trial,” Neurology 59, no. 7 (2002):1015-1021.CrossRefGoogle Scholar
Guy, G.P., Zhang, K., Bohm, M.K., et al., “Vital Signs: Changes in Opioid Prescribing in the U.S., 2006-2015,” MMWR Morbidity and Mortality Weekly Report 66, no. 26 (2017): 697–704CrossRefGoogle Scholar
Chen, Q., Larchelle, M.R., Weaver, D.T., et al., “Prevention of Prescription Opioid Misuse and Projected Overdose Deaths in the U.S.,” JAMA Network Open 2, no. 2 (2019): e187621.Google Scholar
Id.; Pitt, A.L., Humphreys, K., and Brandeau, M.L., “Modeling Health Benefits and Harms of Public Policy Responses to the US Opioid Epidemic,” American Journal of Public Health 108, no. 10 (2018): 1394–1400.CrossRefGoogle Scholar
Pitt, id.Google Scholar
Chen, supra note 60.Google Scholar
“Abuse-Deterrent Formulation of Opioids: Effectiveness and Value,” Institute for Clinical and Economic Review (2017).Google Scholar
Wagner, A., “States Have Stalled on Potential Opioid Abuse Solution: Deterrent Formulation Drugs,” MultiState Insider website, available at <https://www.multistate.us/blog/state-efforts-have-stalled-on-potential-opioid-abuse-solution-deterrent-formulation-drugs> (last visited April 3, 2020).+(last+visited+April+3,+2020).>Google Scholar
<https://www.help.senate.gov/imo/media/doc/The%20Opioid%20Crisis%20Response%20Act%20of%202018%20summary.pdf>(last visited May 1, 2019).(last+visited+May+1,+2019).>Google Scholar
Chou, R., Fanciullo, G.J., and Fine, P.G. et al., “Clinical Guidelines for the use of Chronic Opioid Therapy in Chronic Non-cancer Pain,” Journal of Pain 10, no. 2 (2009): 113-130.CrossRefGoogle Scholar